CD34 and neoplasm: Considering that not only large and mid-sized, but small blood vessels, harbor CD34+ cells within the outermost layer of their wall, adventitial VW-SPCs are omnipresent in vivo this vasculogenic potential might affect the efficacy of anti-angiogenic tumor therapy.